Wright Medical Group Reaches Financial Agreement With BioMimetic’s CEO

Medical device maker Wright Medical Group has agreed to buy BioMimetic Therapeutics for $380 million and has reached a financial agreement with Sam Lynch, MD, BioMimetic CEO, according to the Nashville Business Journal.

Advertisement

Dr. Lynch will receive a $1.25 million bonus for work related to the augment bone graft device. He will also receive $160,275 for unused vacation and $261,632 as a bonus for the year.

More Articles on Devices:
Ohio Third Frontier Gives $3M to Medical Device Partnership Fund
Dr. Paul Sawin Performs First Spine Surgery With PCM Cervical Disc
9 Orthopedic Devices Launched, Cleared in December

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.